Nanoveu Limited (ASX: NVU) aims to become a market leading technology company by applying nanotechnology to deliver vision shaping applications to digital screens. Nanoveu’s award-winning product, EyeFly3DTM, uses a combination of software (application) and hardware (screen protector) to offer real time, affordable and easy to use 3D rendering and 2D-to-3D instant conversion of videos and photos on smartphones and tablets – without the use of 3D glasses.
Nanoveu Pte Ltd is a Singaporean company which was established in 2012 to continue development of and commercialise nanoimprint science applications initiated by A*STAR. Nanoveu Ltd was incorporated in February 2018 for the primary purpose of acquiring Nanoveu Pte Ltd (Nanoveu). A*STAR’s Institute of Materials Research and Engineering worked with Temasek Polytechnic to develop a patented technology for an efficient and low-cost nanoimprint lithography (NIL) manufacturing process.
Nanoveu is also developing its complementary EyeFyx technology through its ongoing research and development program. Using the EyeFyx technology (which comprises a combination of hardware and software), the Company is working towards developing a product which aims to correct images for certain vision aberrations on high resolution digital devices, such as smartphones and tablets.
Nanoveu Limited is looking to raise between $4.5 - $6 million and will have an estimated market capitalisation of $26.5 million at maximum subscription.
The proceeds from the Offer will be used for:
The product development and test sales programs have been completed for the EyeFly3DTM product, and its “EyeFyx” technology is moving towards commercialisation following completion of the proof of concept stage.
The EyeFly3DTM is a nanoimprinted protective film that allows users to view 3D images, videos, and games on the go through their mobile devices. The protective screen protector is low-cost, thin, sensitive and flexible. EyeFly3DTM screens are available in Polyethylene terephthalate (PET) or Tempered Glass, and is oleophobic and anti-fingerprint. Users can download the mobile app and view images and videos in 3D. They can also convert their 2D images into 3D.
Nanoveu’s EyeFly3DTM product utilises Nano Imprint Lithography (NIL) in the manufacturing process. NIL is an advanced patterning technique effective for sub-100 nanometre applications. Advantages of using NIL in the manufacturing process include:
Using Eyefyx, the Company intends to offer the world’s first, commercial, ground-breaking solution of applying a simple nanotech-based screen protector over a smart device/tablet/laptop that works with the appropriate software to correct anyone with farsightedness (hyperopia) and presbyopia.
Nanoveu has developed a technique that adjusts images displayed on a digital device to enable users with hyperopia or presbyopia to view digital content without needing to wear their reading glasses. The technique uses special embedded software and nano-imprint lens technology to render a clear image onto the retina, as opposed to correcting the user’s vision with glasses. This process is illustrated below:
As Nanoveu’s EyeFly3DTM product is comprised of both a screen with nano-lenses (an active screen) and software (the EyeFly3DTM app), Nanoveu is able to generate revenue through sales of both hardware and software.
This is initially intended to be achieved through a retail strategy focussed on the US via shopping mall booths/shops/carts and online channels globally, with the aim of generating sufficient demand to transition to a primary wholesale distribution approach.
The US is the initial target market for which Nanoveu has established a team with retail sales experience and reach in the sector, plus established experience and reach selling to big box retailers
The Company plans to establish online channels and will engage in digital marketing campaigns to create awareness and harvest interest into sales.
The Company also intends to be proactive in searching for distributors, a key source for which is trade shows, plus the overall interest is expected to attract further enquiries.
The key investment highlights for Nanoveu include:
Nanoveu Limited is led by a carefully selected and experienced team with a broad range of business knowledge and skill base to commensurate with the requirements of the company. These include:
You are encouraged to read the Prospectus carefully as it contains detailed information about the Company and the Offer. Like all investments, an investment in the Company carries risk. As set out in Section 8 of the prospectus, Nanoveu Limited is subject to a range of risks, including but not limited to research and development, intellectual property rights, competition and reliance on key personnel.
Section 734(6) disclosure: The issuer of the securities is Nanoveu Limited ACN 624 421 085. The securities to be issued are ordinary shares. The disclosure document for the offer can be obtained by clicking on the link above. The offers of the securities are made in, or accompanied by, a copy of the disclosure document. Investors should consider the disclosure document in deciding whether to acquire the securities. Anyone who wants to acquire the securities will need to complete the application form that will be in or will accompany the disclosure document (which can be done via the electronic application form which will become available by clicking the bid button above).
OnMarket has a limited allocation. The offer may close early and the 'Pay By' dates may change. Bids over $10,000 may be scaled back more heavily. Duplicate bids under the same investment profile, investor name or residential address may be cancelled.
Tap 'More Info' to get access to free research, all company releases, and invest instantly for shares.
Fiji Kava Ltd (ASX: FIJ) is focussed on the research, development and sale of medicinal kava extracts as a consumer product. The Company currently sources, produces and markets high quality kava products and intends to export and sell in Australia, USA, New Zealand and Hong Kong. These products include shots, powders, and capsules designed to promote relaxation, enhance sleep and reduce stress. The Company has established a 111-acre farm processing and extraction facility in Fiji with the aim of establishing the foundation for large scale production and sourcing of kava products.
Hearts and Minds Investments Ltd (ASX: HM1) aims to provide investors with a concentrated portfolio of highest conviction stock ideas from Australia’s leading Fund Managers, while also supporting Australian medical research institutes. The portfolio will consist of ~25 local and international listed securities as selected by leading fund managers including Magellan, Caledonia, Paradice Investment Management, Cooper investors and Regal Funds Management. Cornerstone commitments of $225 million have been received from sophisticated famility investors and other groups associated with the offer.
OnMarket is proud to be acting as a Broker to the Offer.
Shekel Brainweigh Ltd (ASX: SBW) is a profitable company specialising in the development of complex, high precision weighing technology, employing a multidisciplinary team of experts in the fields of analogue and digital scaling technology, AI and big data analytics, alongside a sales team with a proven track record in the global retail and healthcare markets. Customers include Toshiba, Fujitsu, Datalogic, Diebold-Nixdorf and GE Healthcare.
Nanoveu Limited (ASX: NVU) is an Australian innovative technology company, whose primary business is the development, distribution and licensing of 3D technology applications for the global smartphone market. Nanoveu’s EyeFly3DTM product uses a combination of software (application) and hardware (screen protector) to offer real time, affordable and easy to use 3D rendering and 2D-to-3D instant conversion of videos and photos on smartphones and tablets – without the use of 3D glasses.
AXS Group Limited (ASX Code: AXS) is an integrated software solution provider to the finance, insurance and funds sector. With over 40 clients in Australia, North America, Europe and Asia they are focussed on helping clients with their digital transformation, reducing time and cutting costs. The Company’s cloud based ARMnet platform currently is used to manage over $100 billion of assets and transactions that are accessible via smart phones, tablets or email from anywhere at any time.
Norwest Minerals Limited (ASX:NWM) is a gold and base metals exploration company with projects located among world-class mineral discoveries in Western Australia and boasts exciting walk-up drill targets. The Company has received binding firm commitments totalling $4,000,000 and is led by CEO, Charles Schaus, who has extensive experience as a manager in the resource industry. Norwest’s strategy is to focus on delineating an economically viable resource capable of transforming the Company from an explorer into a mineral producer.